GW Pharma (GWPH) Could See $150M of Epidiolex Sales, PT to $215 at JPMorgan
Tweet Send to a Friend
JPMorgan analyst Cory Kasimov raised the price target on GW Pharma (NASDAQ: GWPH) to $215.00 (from $180.00) after Epidiolex sales ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
